Burak assumes the leadership role after more than two decades in the pharmaceutical industry across multiple markets.
In his new role, Burak will oversee the company’s operations in Vietnam, with a focus on expanding patient access to advanced medical science and technology through partnerships with the healthcare sector.
Burak Pekmezci, General Manager of Roche Pharma Vietnam. Photo courtesy of Roche Pharma Vietnam |
Most recently, he led the vaccines business across Vietnam and Cambodia, focusing on increasing immunization rates, protecting public health, and broadening access to innovative medicines. He also serves on the board of Pharma Group, the pharmaceutical sector committee of the European Chamber of Commerce in Vietnam (EuroCham).
According to the company, Burak’s experience in healthcare access, health systems, and policy engagement aligns with Roche Pharma Vietnam’s priorities in Vietnam. The company said these are among its priority therapeutic areas in Vietnam, where early diagnosis and timely treatment can significantly improve patient outcomes.
 |
Burak Pekmezci with Roche Pharma Vietnam’s team in Hanoi. Photo courtesy of Roche Pharma Vietnam |
“Vietnam has set ambitious development goals, and a healthy population is one of the strongest foundations for achieving them,” Burak said.
“I am honored to work alongside the team and our partners across the healthcare sector to contribute to the sustainable and comprehensive development of Vietnam’s healthcare system—from strengthening clinical capacity and early detection to broadening timely access to scientific progress. This is about doing now what patients need next.”
 |
Burak visits K Hospital. Photo courtesy of Roche Pharma Vietnam |
Roche, founded in Basel, Switzerland in 1896, provides medicines, diagnostics and digital healthcare solutions in more than 150 countries. Roche Pharma Vietnam has operated in the country for more than 30 years, working with government agencies, hospitals, and research institutes to strengthen healthcare capacity, improve treatment outcomes, and expand access to innovative therapies. The company said it will continue collaborating with healthcare stakeholders to support the sustainable development of Vietnam’s healthcare system.
Comments are closed.